Lupin Achieves Top ESG Ratings in Climate and Water Security
Event summary
- Lupin received the highest 'A' leadership rating from CDP for Climate Change and Water Security in 2026.
- The company's ratings improved from 'A-' in 2024 and 'B'/'C' in 2023, showing significant year-over-year progress.
- Lupin also achieved an S&P Global ESG score of 91 in 2025, placing it among the top global performers.
- The recognition highlights Lupin's commitment to sustainability, including reducing carbon emissions and responsible water management.
The big picture
Lupin's top ESG ratings reflect a broader industry trend where pharmaceutical companies are increasingly prioritizing sustainability to meet regulatory demands and investor expectations. The company's progress in climate and water security initiatives positions it as a leader in corporate environmental responsibility, which could enhance its brand value and operational resilience.
What we're watching
- Sustainability Leadership
- How Lupin's top ESG ratings will influence its competitive positioning in the global pharmaceutical market.
- Regulatory Compliance
- Whether the company can maintain its high ESG standards amid evolving environmental regulations.
- Investor Appeal
- The impact of Lupin's ESG achievements on attracting ESG-focused investors and partnerships.
Related topics